ATORVASTATIN 20mg. IP + CLOPIDOGREL 75mg. IP + ASPIRIN 75mg. IP

A ternary combination of blood-thinning and cholesterol-lowering drugs is used for atherosclerotic patients suffering from various heart diseases. (S. V. Londhe, 2011) A potent treatment of choice in acute coronary syndromes and prevention of thrombosis after coronary stent implementation. (A.M. SPIRIDON, 2015) Blocks the platelet adenosine diphosphate receptor, and powerfully inhibits platelet activation, degranulation, and aggregation. (Jehangir N Din, 2005) A therapeutic strategy that reduces cardiovascular risk, prevents ischemic stroke, myocardial infarction, and vascular disease. (S. V. Londhe, 2011) Reduces total cholesterol levels, low-density lipoprotein-cholesterol, triglyceride, and very low-density lipoprotein cholesterol and increases high-density lipoprotein-cholesterol. (H S Malhotra, 2001) Decreases the incidences of ischemic events and ameliorates survival in patients with acute coronary syndromes. (A.M. SPIRIDON, 2015) A potent drug that has the ability to reduce cardiovascular disease by stopping the growth of plaques in artery walls. (Ursula Gresser, 2004)